Shunguang Zhou

Discovery andw biological evaluation of novel 6,7-disubstituted-4-(2-fluorophenoxy)quinoline derivatives possessing 1,2,3-triazole-4-carboxamide moiety as c-Met kinase inhibitors

Shunguang Zhou, Huimin Liao, Mingmei Liu et al. · Bioorganic & Medicinal Chemistry · 2014 · 60 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +9

Design, synthesis and structure–activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents

Shunguang Zhou, Huimin Liao, Chao He et al. · European Journal of Medicinal Chemistry · 2014 · 35 citations · Full text

Medicinal Chemistry, Biochemistry, Natural Sciences +10

Design, synthesis and pharmacological evaluation of 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents

Shunguang Zhou, Jian-Guo Ren, Mingmei Liu et al. · Bioorganic Chemistry · 2014 · 32 citations · Full text

Medicinal Chemistry, Medicine, Pharmacological Agent +10

Discovery of a novel 6,7-disubstituted-4-(2-fluorophenoxy)quinolines bearing 1,2,3-triazole-4-carboxamide moiety as potent c-Met kinase inhibitors

Mingmei Liu, Yunlei Hou, Weile Yin et al. · European Journal of Medicinal Chemistry · 2016 · 30 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Biochemistry +9

Design, synthesis and structure–activity relationship of oxazolidinone derivatives containing novel S4 ligand as FXa inhibitors

Yanfang Zhao, Mingyan Jiang, Shunguang Zhou et al. · European Journal of Medicinal Chemistry · 2015 · 15 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Oxazolidinone Derivatives +9